23
HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS Carbamezapine Co-trimixazole 2. HOW CAN WE MINIMIZE RESISTANT IN ANTICANCER DRUG Drug combination Short term therapy High dose Turn down thermostat. All are correct 3. ALL ARE MATCHED CORRECTLY REGARDING A SIDE EFFECT OR A MECHANISM OF ACTION, EXCEPT : Bleomycin>> Mitotic spindle Vincristina>>thrombophilites

HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

HEMATOPOIETIC & LYMPHATIC SYSTEM

- PHARMACOLOGY -

PULSE

1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS

☐ Carbamezapine

☐ Co-trimixazole

2. HOW CAN WE MINIMIZE RESISTANT IN ANTICANCER DRUG

☐ Drug combination

☐ Short term therapy

☐ High dose

☐ Turn down thermostat.

☐ All are correct

3. ALL ARE MATCHED CORRECTLY REGARDING A SIDE EFFECT OR A MECHANISM OF

ACTION, EXCEPT :

☐ Bleomycin>> Mitotic spindle

☐ Vincristina>>thrombophilites

Page 2: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

4. TREATMENT OF CHRONIC IRON TOXICITY IS DONE BY:

☐ Acid base and fluid

☐ Oral phosphate or carbonate

☐ Venesection

5. PREGRANT WOMEN IN THE 8TH MONTH OF PREGRANCY WITH IDA, IS TREATED BY:

☐ High dose of oral iron

☐ IV iron ( dextran )

6. WARFARIN:

☐ It is a mucopolysaccharide

☐ It is competitively inhibits Epoxide Reductase

7. WHICH F FOLLOWING NOT CORRECT REGARDING THE COMPARE BETWEEN LMHW

AND HEPARIN:

☐ LMWH is a result from the depolymerization of heparin

☒ LMWH is a dose independent ( FOK )

☒ LWHW has shorter half life

8. PATIENT WITH RENAL FAILURE IS TREATED WITH HEPARIN, SUDDENLY DEVELOPED

THROMBOCYTOPENIA, THE TREATMENT AFTER WE STOP THE DRUG IS :

☐ Lepiradin

☐ Warfarin

☐ Argatroban

Page 3: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

9. WHICH OF THE FOLLOWING DRUGS HAS NO IMMUNOSUPPRESSOR EFFECT :

☐ Interferon (( not sure ))

10. TAMOXIFEN IS USED IN THE TREATMENT OF :

☐ Breast cancer in males

☐ Breast cancer in females

EHSAN

11. WHICH OF THE FOLLOWING DRUGS IS USED IN PATIENTS WITH CHRONIC RENAL

FAILURE?

☐ Epoetin

12. CICLOSPORINE IS:

☐ Used in organ transplantation for immune suppression

13. WHICH OF THE FOLLOWING DRUGS USAGE IS LIMITED BY ITS ADVERSE EFFECT OF

CARDIOTOXICITY?

☐ Doxorubicin

14. WHICH OF THE FOLLOWING DESCRIBES HOW DOXORUBICIN WORKS?

☐ Free radical generator that inhibits NA synthesis

Page 4: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

15. WHICH OF THE FOLLOWING ISN’T ONE OF THE PRINCIPLES USED IN CANCER

CHEMOTHERAPY?

16. A PATIENT THAT HAS RECENTLY RECOVERED FROM A STROKE HAS BEEN PLACED ON

TICLOPIDINE THERAPY. WHICH OF THE FOLLOWING BEST DESCRIBES THE

MECHANISM OF ACTION OF TICLOPIDINE?

☐ Inhibits the production of ADP resulting in inhibition of platelet aggregation

17. WHICH OF THE FOLLOWING STATEMENTS IS INCORRECT

☐ LMWH follows zero order kinetics while heparin follows first order kinetics

18. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS?

☐ Rifampin

☐ Carbamezapine

☐ Co-trimixazole

19. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS?

☐ Cimetidine

20. ALTEPLASE IS:

☐ Clot selective in its action

☐ Not antigenic like streptokinase

☐ Is recombinant t-PA

☐ All of the following are correct

☐ The usage of drugs that have the same mechanism of action or affect at same stage of cell cycle.

Page 5: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

21. WHICH OF THE FOLLOWING DRUGS MUST NOT BE USED FOR THE TREATMENT OF

ROCKY MOUNTAIN SPOTTED FEVER?(QUESTION WAS REPEATED TWICE IN EXAM)

☐ Streptomycin

☐ Doxycycline

☐ Sulfonamides

☐ Chloramphenicol

☐ Erythromycin

HOPE

22. PERNICIOUS ANEMIA IS BEST INITIALLY TREATED BY INITIALLY BY:

☐ Parenteral hydroxocobalamin

23. WHICH OF THE FOLLOWING DRUGS IS USED IN THE TREATMENT OF PATIENTS WITH

PERSISTENT NEUTROPENIA DUE TO HIV INFECTION:

☐ Molgramostim

24. PATIENTS WHO IS STABILIZED ON WARFARIN FOR FEW MONTHS SUDDENLY HAS

SEVERE NASAL BLEEDING, INR = 7, THIS PATIENT WAS ADVISED TO STOP WARFARIN

AND TREATED IMMEDIATELY WITH:

☐ Phytomenadione

25. HEPARIN DOSE ADJUSTMENT IS BY:

☐ Measurement of aPTT.

Page 6: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

26. 65 YEARS OLD MALE, WITH PREVIOUS HISTORY OF STROKE IS TREATED BY ASPIRIN AS

A PROPHYLAXIS AND PREVENTION IF FURTHER STROKES, WHICH OF THE FOLLOWING

IS CONSIDERED THE EFFECTIVE MECHANISM OF ACTION OF ASPIRIN:

☐ Irreversible inhibition of platelets TXA2

27. ALL OF THE FOLLOWING DRUGS ARE CORRECTLY MATCHED WITH THEIR ANTIDOTES

EXCEPT:

☐ Methotrexate --- folic acid

28. WHICH OF THE FOLLOWING IS THE EFFECTIVE MECHANISM OF ACTION OF

VENCRISTINE:

☐ Inhibition of function of microtubules.

29. CARDIOTOXICITY LIMITS THE CLINICAL USEFULNESS OF THE FOLLOWING DRUG:

☐ Doxorubicin

30. THE ADVERSE REACTION OF CYTOTOXIC DRUGS THERAPY WHICH MIGHT BE SEVERE

AND REGARDED AS THE MAIN CAUSE OF TREATMENT REJECTION:

☐ Nausea and vomiting

31. WHICH OF THE FOLLOWING DRUGS HAS NO IMMUNOSUPPRESSOR EFFRCT:

☐ Abciximab

32. WHICH OF THE FOLLOWING TREATMENT IS THE MOST ACCURATE:

☐ Anemia prevention program among young children

Page 7: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

SAMA AND

BEFORE

33. WHICH OF THE FOLLOWING IS MISMATCHED WITH ITS SPECIFIC SIDE EFFECT:

☐ Methotrexate --- nephrotoxicity

☐ Vinblastin --- skin hyperpigmentation

☐ Doxorubicin --- cardiotoxocity

☐ Bleomycin --- pulmonary toxicity

34. ALL OF THE FOLLOWING ARE CORRECT CONCERNING CHEMOTHERAPY EXCEPT:

☐ Small intermittent doses are better than high doses

35. WHICH OF THE FOLLOWING IS A SIDE EFFECT OF RADIOTHERAPY:

☐ Pneumonitis

36. CICLOSPORIN IS:

☐ Immunosuppressant agent used to prevent rejection of transplanted tissue.

☐ Used in Hodgkin lymphoma

☐ Used in breast cancer

37. ASYMMETRIC SUBSTITUTION OF THE ACETATE AND PROPIONATE IS SEEN IN:

☐ Porphyrin 3

☐ Porphyrin 1

☐ Porphyrin 2

Page 8: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

38. HEPARIN IS:

☐ Given with monitoring of APTT

☐ Share the same structure with vitamin K

39. WHICH OF THE FOLLOWING IS USED IN CANCER TREATMENT :

☐ Chemotherapy

☐ Radiotherapy

☐ Surgery

☐ Antibodies

☐ All of the above

40. IRON SUPPLEMENT IS INDICATED IN ALL OF THESE DISORDERS EXCEPT:

☐ Talassemia

☐ IDA

☐ Hook worm infection

41. THE ANTICOAGULANT ACTIVITY OF WARFARIN CAN POTENTIATED BY ALL OF THE

FOLLOWING EXCEPT:

☐ Rifampin

☐ Aspirin

☐ Acute alcohol intoxication

☐ Phenylbutazone

☐ Cimetidine

Page 9: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

42. MYELOSUPPRESSION (OR APLASTIC ANEMIA) IS A PARTICULARLY SERIOUS TOXICITY

WITH ALL OF THE FOLLOWING EXCEPT:

☐ Vinblastine

☐ Cyclophosphamide

☐ Cytarabine

☐ Mechlorethamine

☐ Asparaginase

43. A PATIENT WITH CHRONIC RENAL FAILURE PRESENTED TO YOU WITH FATIGUE. HER

HB WAS 7.2 WITH A NORMOCYTIC NORMOCHROMIC BLOOD FILM. THE DRUG THAT

WILL MOST LIKELY IMPROVE HER CONDITION IS:

☐ Ferrous sulphate

☐ Iron dextran

☐ Hydroxycobolamine

☐ Erythropoietin

☐ Folate supplements

44. SELECT THE CORRECT PAIRING OF AN ANTICANCER DRUG AND ITS CLASS:

☐ Vincristine → antimetabolites

☐ Methotrexate → folate analogues

☐ Cisplatin → plant alkaloids

☐ Bleomycin→ alkylating agent

☐ All of the above

45. ALL THE FOLLOWING STATEMENTS ABOUT CYCLOPHOSPHAMIDE ARE CORRECT,

EXCEPT:

☐ It is active orally

☐ It can be complicated with nausea and vomiting

☐ It is a cell cycle-non specific agent

Page 10: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

☐ It belongs to the anti-metabolite class of antineoplastic agents

☐ It is converted to cytotoxic metabolite by the liver

46. IN THE MANAGEMENT OF THROMBOEMBOLISM:

☐ Alteplase directly converts fibrin bound plasminogen to plasmin

☐ Vitamin K is used for rapid reversal of plasmin-induced bleeding

☐ Streptokinase is a directly acting fibrinolytic agent

☐ Dipyridamol inhibits the synthesis of clotting factors in the liver

☐ Aspirin can be used in large doses

47. ALL OF THE FOLLOWING STATEMENTS ABOUT ANTICOAGULANT ARE TRUE, EXCEPT:

☐ Low molecular weight heparin (Enoxaprin) is not active orally.

☐ Parenteral administration of warfarin provides immediate anticoagulant

☐ Heparin effect is associated with antithrombin III

☐ Warfarin can be transported to the fetus

☐ Heparin overdose can be reversed by protamine sulfate administration

48. ACTIVATION OF PLASMINOGEN TO PLASMIN CAN BE INDUCED BY ALL OF THE

FOLLOWING AGENTS, EXCEPT:

☐ Streptokinase

☐ t-PA

☐ Anistreplase

☐ Antithrombin III

☐ Urokinase

Page 11: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

49. WHICH OF THE FOLLOWING STATEMENT ABOUT HEPARIN IS FALSE?

☐ It is safe in early pregnancy

☐ It is monitored therapeutically by prothrombin time

☐ It is effective in vitro

☐ It mediated its effects by enhancing antithrombin III effects

☐ Its prolonged use might be complicated with thrombocytopenia

50. WHICH OF THE FOLLOWING IS FALSE ABOUT IRON POISONING?

☐ Acute poisoning can be complicated with GI bleeding and diarrhea

☐ Chronic iron overload leads to hemosiderosis

☐ Acute intoxication with iron can be complicated with metabolic alkalosis

☐ Frequent blood transfusion can be complicated with chronic iron toxicity

☐ Desferrioxamine is indicated in the management of acute iron poisoning

51. TARGETING THE GAMETOCYTES OF FALCIPARUM MALARIAE AND PREVENTING THE

TRANSMISSION OF THE DISEASE IS ACHIEVED BY TREATMENT WITH:

☐ Chlorquine

☐ Sulfonamides

☐ Primaquine

☐ Pyrimethanamine

☐ Melarsoprol B

52. WHAT IS THE DRUG OF CHOICE FOR THE TREATMENT OF MENINGO ENCEPHALITIS

CAUSED BY TRYPANOSOMA BRUCEI?

☐ Tetracycline

☐ Allopurinol

☐ Melarsoprol B

☐ Suramin

Page 12: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

☐ Pentamidine

53. INDICATIONS OF PARENTERAL IRON PREPARATIONS ARE?

☐ . Iron can not be absorbed from GIT.

☐ A sure and definite response is needed.

☐ Non compliance.

☐ All of the above

54. TT OF CHRONIC IRON TOXICITY IS DONE BY?

☐ Oral phosphate or carbonate to precipitate iron.

☐ Venesection in non anemic

☐ Acid base, fluid and electrolyte correction

55. CLINICAL USES OF FOLIC ACID ARE ALL OF THE MENTIONED BELOW EXCEPT?

☐ Chronic hemolytic anemia

☐ Prevention of spina bifida

☐ TT of pernicious anemia and improvement of the neurological picture

☐ Anticonvulsants

56. TO REDUCE SEVERITY AND DURATION OF NEUTROPENIA WE USE WHICH OF THE FOLLOWING?

☐ IL-11 “Oprelvekin”

☐ GM-CSF & G-CSF

☐ Erythropoietin

57. HEPARIN?

☐ Strongest acid in the body with a positive charge.

☐ Both in vivo and in vitro.

☐ Dose adjustment by PT

Page 13: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

58. WHICH OF THE FOLLOWING IS FALSE REGARDING HEPARIN?

☐ Antidote “Protamine sulphate”

☐ Injectable “Parentral”

☐ A powerful anti-coagulant

☐ An effective anticoagulant even in the absence of Anti thrombin III

59. PATIENT WHO IS STABILIZED ON WARFARIN FOR FEW MONTHS SUDDENLY HAS

SEVERE NASAL BLEEDING, INR=7, THIS PATIENT WAS ADVISED TO STOP WARFARIN

AND SHOULD BE GIVEN?

☐ Phytomenadione

☐ Protamine

☐ MESNA

60. WHEN USED WITH THIS SPECIFIC DRUG, OACS DOSAGE SHOULD BE REDUCED (I DON'T

KNOW IF I WROTE THE QUESTION PROPERLY)?

☐ Phenytoin

☐ Cimetidine

☐ Rifampin

61. CLOPIDOGREL?

☐ Inhibitors of TXA2 production

☐ Inhibitors of ADP receptors

☐ Inhibitors of platelet aggregation

☐ Irreversibly acetylating COX-1

Page 14: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

62. ALL ARE TRUE REGARDING CYTOTOXIC DRUGS EXCEPT?

☐ Recovery of normal cells from toxic effects of the drugs is faster and better than that of malignant cells

☐ Small continuous doses are better than full intermittent doses

☐ ADRs of the drugs should be diverse and not centered on the same organ system.

63. WHICH OF THE FOLLOWING IS MIS-MATCHED?

☐ Mercaptopurine--- Hepatotoxicity

☐ Vincristine --- skin hyper-pigmentation

☐ Methotrexate --- Nephrotoxicity

64. CICLOSPORINE?

☐ Used in organ transplantation

☐ Anti TNF – alpha agent

☐ Interferes with purine synthesis

65. WHAT IS THE FUNCTION OF ANTILYMPHOCYTE GLOBULINS (ALG) AND

ANTILYMPHOCYTE GLOBULINS (ATG)?

☐ Treating autoimmune disease

☐ Preventing rejection of transplanted organ

☐ Treating rheumatoid arthritis

☐ All

Page 15: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

66. WHICH OF THE FOLLOWING IS NOT IMMUNOSUPPRESSANT DRUGS?

☐ Cyclosporine

☐ Prednisone

☐ Mycophenolatemofetil

☐ Bleomycin

67. CHOOSE THE WRONG COMBINATION

☐ Monoclonal antibodies - neutropenia

☐ Mycophenolatemofetil - given with cyclosporine to reduce nephrotoxicity

☐ Etanercept- rheumatoid arthritis

☐ Rho immunoglobulins- prevent Rh hemolytic disease of newborn

68. WHICH OF THE FOLLOWING IS NOT SPECIFIC SIDE EFFECTS OF CYCLOSPORINE AND

TACROLIMUS:

☐ Neurotoxicity

☐ Hyperglycemia

☐ Hypertension

☐ Cardiotoxicity

☐ Hyperlipidemia

69. CHOOSE A WRONG COMBINATION:

☐ Methrotrexate - specific side effects are pneumonia and nephrotoxicity

☐ Cytabarine - inhibit DNA synthesis at M phase

☐ Mercatopurine - hepatotoxicity

☐ Flurouracil- inhibit thymidylatesynthetase

Page 16: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

70. WHICH OF THE FOLLOWING IS WRONG:

☐ Antidotes for acroline is MESNA

☐ Doxorubicin is associated with cardiotoxicity and congestive heart failure

☐ Vincristine inhibits mitosis at S phase

☐ Allergic patients are pretreated with steroid and antihistamine drug

☐ Estrogen is used to treat breast cancer In males

71. ALL THE FOLLOWING ARE SPECIFIC SIDE EFFECTS OF PACLITAXEL EXCEPT:

☐ Thrombophlebitis

☐ Fluid retention

☐ Neurotoxicity

☐ Hypersensitivity

72. HEPATOTOXICITY, NEPHROTOXICITY AND NEUROTOXICITY ARE ASSOCIATED WITH

WHICH DRUG?

☐ Asparaginase

☐ Cisplastin

☐ Busulfan

☐ Procarbazine

73. WHICH IS THE SPECIFIC SIDE EFFECTS OF PROCARBAZINE?

☐ Disulfiram like reaction

☐ MES inhibitor

☐ Nephrotoxicity

☐ A & B

☐ All

Page 17: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

74. PANCREATITIS AND SEIZURES ARE SPECIFIC SIDE EFFECTS OF WHICH DRUG?

☐ Cisplastin

☐ Procarbazine

☐ Asparginase

☐ Doxorubicin

75. WHICH DRUG HAS ANTIVIRAL AND ANTINEOPLASTIC EFFECTS?

☐ Doxorubicin

☐ Mustine

☐ Vinblastine

☐ Interferons

76. CHOOSE A CORRECT COMBINATION:

☐ Abxicimab&tirofiban- Platelet aggregation inhibitor

☐ Aspirin - TXA2 inhibitors

☐ Ticlopidine&clopidogrel- ADP receptors inhibitor

☐ All

77. WHICH OF THE FOLLOWING IS WRONG:

☐ A baby aspirin is sufficient to produce antiplatelet effects

☐ Neutropenia is associated with long term use of ticlopidine

☐ Antiplatelet drug is the first choice of treating arterial fibrillation

☐ Intermittent claudication is treated with antiplatelets drugs

☐ Main side effects of antiplatelets drugs are bleeding

☐ Dipyridamole causes accumulation of C AMP and little vasodilator effect

Page 18: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

78. WHICH OF THE FOLLOWING IS NOT FIBRINOLYTICS AGENTS?

☐ Alteplase

☐ Tranexamic acid

☐ Urokinase

☐ Anistreplase

79. IF THE BLEEDING IS SERIOUS PRIOR TO THE USE OF FIBRINOLYTIC AGENTS, WHICH IS

NOT THE TREATEMENT?

☐ Tranexamic acid

☐ Fresh plasma

☐ Clotting factors

☐ Protalminesulphate

80. CHOOSE THE WRONG COMBINATION

☐ Streptokinase- have antistreptococcal antibodies formed after 4 days administration

☐ Alteplase- clot selective

☐ Reteplase- short lived effect and given IV infusion

☐ Streptokinase - cause allergy and hypotension

81. WHICH IS NOT THE CLINICAL USES OF TRANEXAMIC ACID?

☐ Menorrhagia

☐ Epistaxis

☐ Dental extraction

☐ Prostatectomy

☐ Unstable angina

Page 19: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

82. WHEN THERE IS RECENT THROMBOEMBOLISM FOLLOWING FIBRINOLYTIC

OVERDOSE, WHAT IS THE BEST CURE?

☐ Aprotinin

☐ Menadiol sodium phosphate

☐ Tranexamic acid

☐ Phytomenadione

83. TREATMENT OF IRON DEFICIENCY ANEMIA CONSIST OF:

☐ Correction of underlying cause

☐ Iron replacement therapy

☐ A&B

☐ None

84. WHICH OF THE FOLLOWING INTERFERE IRON ABSORPTION?

☐ Tetracycline

☐ Levodopa

☐ Captopril

☐ egg yolk

☐ All

85. FERROUS SUCCINATE ELIXIR AND FERROUS FUMARATE SYRUP ARE RARELY USED

BECAUSE IT CAUSE:

☐ Fertility

☐ Dark brown teeth

☐ Red urine color

☐ Inhibit iron absorption

Page 20: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

86. WHICH IS FALSE ABOUT IRON ORAL PREPARATION?

☐ Ferrous sulphate, fumarate& succinate arepreferred

☐ One of the side effect is blacken feces

☐ It starts by giving small doses and increase gradually to avoid GIT upset

☐ None

87. WHICH OF THE FOLLOWING IS WRONG?

☐ Imferon ( Iron dextran ) can be given IM or IV

☐ Jectofer ( Iron sorbitol ) can be given IV only

☐ IM injection must be given deeply injected to prevent iron leakage and causing skin discoloration into

dark brown

☐ None

88. IRON TOXICITY MAY CAUSE THE FOLLOWING EXCEPT:

☐ Hypovolemic shock

☐ Impaired oxidative phosphorylation

☐ Electrolyte loss

☐ Cirrhosis

89. WHICH OF THE FOLLOWING IS FALSE REGARDING HEPARIN?

☐ Venesection in anemic patients

☐ Oral PO4 & CO3

☐ Iron chelation like desferrioxamine ( desferal )

☐ All

Page 21: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

90. WHICH IS FALSE ABOUT B12 DEFICIENCY?

☐ Associated with megaloblastic anemia

☐ May lead to subacute combined degeneration of spinal cord

☐ Can be treated with cyano by IM injection if case of pernicious anemia

☐ Low doses of oral hydroxycobalamin can be used to treat cyanide poisoning

91. NEURONAL TUBE DEFECT KNOWN AS SPINA BIFIDA IS MOSTLY SUITABLE TREATED BY

USING:

☐ vitamin B12

☐ Folic acid

☐ Vitamin C

☐ Folinic acid

92. TRANSIENT INFLUENZA-LIKE SYMPTOMS, ENCEPHALOPATHY AND RISKS OF

THROMBOSIS ARE SOME SIDE EFFECTS FOLLOWING THE USE OF:

☐ Molgrasmostim (GM-CSF)

☐ Filgrastim

☐ Epoetin

☐ Oprelvekin (thrombopoietin)

93. WHICH HGF IS ASSOCIATED WITH DYSUREA AND ABNORMAL LIVER FUNCTION TEST

AS SOME SIDE EFFECTS?

☐ L-CSF

☐ r-erythropoietin

☐ GM-GSF

☐ G-CSF

Page 22: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

94. WHICH DRUG CAN BE INJECTED BY INTRAPERITONEALLY?

☐ Molgrasmostim (GM-CSF)

☐ Filgrastim

☐ Epoetin (erythropoietin)

☐ Oprelvekin (thrombopoietin)

95. WHICH IS FALSE REGARDING PARENTERAL INJECTED ANTICOAGULANTS?

☐ Heparin can be given IV, SC not IM because may lead to hematoma.

☐ Heparin stimulates the action of antithrombin III

☐ Heparin increases postprandial lipemia

☐ Heparin’s effect can be predicted from dose so APTT is not needed

☐ Heparin is the strongest acid in the body with a negative charge

96. ALL THE FOLLOWING IS THE SIDE EFFECTS OF PARENTERAL ANTICOAGULANTS

EXCEPT:

☐ Hepatotoxicity

☐ Bleeding from any site

☐ Osteoporosis

☐ Hypoaldosteronism

97. WARFARIN:

☐ Similar to vitamin K in structure

☐ Inhibits epoxide reductase enzyme

☐ May cross placenta and cause teratogenicity

☐ Its antidotes are fresh blood &phytomenadione

☐ All

Page 23: HEMATOPOIETIC & LYMPHATIC SYSTEM · HEMATOPOIETIC & LYMPHATIC SYSTEM - PHARMACOLOGY - PULSE 1. WHICH OF THE FOLLOWING POTENTIATES THE EFFECT OF ORAL ANTICOAGULANTS ☐ Carbamezapine

98. ANTICOAGULANTS ARE USED FOR THE FOLLOWING PREVENTION EXCEPT:

☐ Hyperkalemia

☐ Deep vein thrombosis-DVT

☐ Thrombosis & embolism in arterial fibrilation

☐ Unstable angina

99. ANTICOAGULANTS ARE CONTRAINDICATED IN WHICH PATIENT?

☐ Advanced cardiac disease

☐ Suspected intracranial hemorrhage

☐ Severe hypotension

☐ All

100. WHICH OF THE FOLLOWING IS USED FOR LYSIS OF THE BLOOD CLOT:

A. Heparin

B. Anti-thrombin III

C. Plasminogen

D. Plasmin

E. All of the above

101. WHICH OF THE FOLLOWING IMPROVES THE FUNCTION OF ANTITHROMBIN III

Answer: Heparin

102. WHICH OF THE FOLLOWING IS USED TO MONITOR THE ORAL ANTICOAGULANT

THERAPY?

Answer: PT (Prothrombin time)